Similarly, HCC cell lines exhibited higher levels of ULBP2 upon exposure to low doses of cisplatin, which was also observed to enhance tumor control in HCC-bearing mice when combined with allogeneic NK cells [134]. Here, ULBP2 is linked to hepatocellular carcinoma.